<?xml version="1.0" encoding="UTF-8"?>
<ref id="B234">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wright</surname>
    <given-names>P. F.</given-names>
   </name>
   <name>
    <surname>Durbin</surname>
    <given-names>A. P.</given-names>
   </name>
   <name>
    <surname>Whitehead</surname>
    <given-names>S. S.</given-names>
   </name>
   <name>
    <surname>Ikizler</surname>
    <given-names>M. R.</given-names>
   </name>
   <name>
    <surname>Henderson</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Blaney</surname>
    <given-names>J. E.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2009</year>). 
  <article-title>Phase 1 trial of the dengue virus type 4 vaccine candidate rDEN4Δ30-4995 in healthy adult volunteers</article-title>. 
  <source>Am. J. Trop. Med. Hyg.</source>
  <volume>81</volume>, 
  <fpage>834</fpage>–
  <lpage>841</lpage>. 
  <pub-id pub-id-type="doi">10.4269/ajtmh.2009.09-0131</pub-id>
  <?supplied-pmid 19861619?>
  <pub-id pub-id-type="pmid">19861619</pub-id>
 </mixed-citation>
</ref>
